Siren »

Alto Neuroscience shares owned by Siren

Quarter-by-quarter ownership of Alto Neuroscience (ANRO) shares owned by Siren from 13F filings

Historical chart of Siren investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.5M 391k 11.44

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics (BCAX)
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Alto Neuroscience

Falcon Edge Capital
RA Capital Management
BlackRock
Franklin Resources
ExodusPoint Capital Management
Point72 Asset Management
Ikarian Capital
Jennison Associates
T. Rowe Price Associates
72 Investment Holdings
Vestal Point Capital
AWM Investment Company
Geode Capital Management
Philadelphia Financial Management of San Francisco
Siren

View all funds holding Alto Neuroscience